Search - tctmd.com

Displaying 421 - 440 of 849

Sort: Relevancy | Date

Presentation TCT 2017

Perfusion-balloon Valvuloplasty Facilitating TAVR Without Rapid Pacing: The TRUE-FLOW Study

Presenter: Nicolo Piazza, Josep Rodés-Cabau, Felix Woitek

October 30, 2017

Presentation TCT 2017

Human Cell Derived Off-The-Shelf Tissue Engineered Heart Valves for Next Generation TAVR: A Proof-of-Concept Study in Adult Sheep

Presenter: Nicolo Piazza, Josep Rodés-Cabau, Valentina Lintas

October 30, 2017

Presentation TCT 2017

First-in-Man Experience With a Large Bore (?14 FR) Bio-Resorbable Vascular Closure Device

Presenter: Nicolo Piazza, Josep Rodés-Cabau, Ronald Caputo

October 30, 2017

Presentation TCT 2017

Transcatheter Aortic Valve Replacement With the HLT Meridian® Valve: Initial Clinical Experience

Presenter: Nicolo Piazza, Josep Rodés-Cabau

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey V: Addressing Complications and Follow-up

Presenter: Martina Kelly Speight, Amy E. Simone

October 30, 2017

Presentation TCT 2017

Effect of a New Enhanced Fluoroscopy Technology (Valve ASSIST2) on Contrast and Radiation Use in Patients Undergoing TAVR

Presenter: Nicolo Piazza, Josep Rodés-Cabau, Ali Shafiq

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey IV: The Hospital Experience

Presenter: Martina Kelly Speight, Sandra Lauck

October 30, 2017

Presentation TCT 2017

Featured Lecture: TAVR Innovation: Unresolved Clinical Issues and Opportunities For Further Technology Optimization

Presenter: Nicolo Piazza, Josep Rodés-Cabau

October 30, 2017

Presentation TCT 2017

Case #4: TAVR for Pure Native Aortic Regurgitation - A Horrifying Ride

Presenter: Jun-Jack Cheng, Wasan Udayachalerm, Wei-Hsian Yin

October 30, 2017

Presentation TCT 2017

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Presenter: A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Presenter: Susheel K. Kodali

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey III: Behind the Scenes

Presenter: Martina Kelly Speight, Sarah Clarke

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey II: Imaging Assessment

Presenter: Martina Kelly Speight, João L Cavalcante

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey I: Initial Evaluation

Presenter: Martina Kelly Speight, Patricia Keegan

October 30, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

Presentation TCT 2017

Case Presentation 6: BTK Intervention

Presenter: Sergey A. Abugov, Juan F. Granada, Zaza Kavteladze

October 29, 2017

Presentation TCT 2017

Editorial Comment

Presenter: Sergey A. Abugov, Juan F. Granada, Susheel K. Kodali

October 29, 2017

Presentation TCT 2017

Case Presentation 5: TAVR

Presenter: Sergey A. Abugov, Juan F. Granada, Alexey Protopopov

October 29, 2017

Presentation TCT 2017

Tricuspid Valve Interventions: Patient Selection, Devices, and Predictions

Presenter: Antonio Colombo, Samir R. Kapadia, Azeem Latib

October 29, 2017

Presentation TCT 2017

Troubleshooting During Left Atrial Appendage Closure

Presenter: Helene Eltchaninoff, Afzalur Rahman, Rabin dra Nath Chakraborty

October 29, 2017

Advertisement

Perfusion-balloon Valvuloplasty Facilitating TAVR Without Rapid Pacing: The TRUE-FLOW Study

Human Cell Derived Off-The-Shelf Tissue Engineered Heart Valves for Next Generation TAVR: A Proof-of-Concept Study in Adult Sheep

First-in-Man Experience With a Large Bore (?14 FR) Bio-Resorbable Vascular Closure Device

Transcatheter Aortic Valve Replacement With the HLT Meridian® Valve: Initial Clinical Experience

TAVR Patient Journey V: Addressing Complications and Follow-up

Effect of a New Enhanced Fluoroscopy Technology (Valve ASSIST2) on Contrast and Radiation Use in Patients Undergoing TAVR

TAVR Patient Journey IV: The Hospital Experience

Featured Lecture: TAVR Innovation: Unresolved Clinical Issues and Opportunities For Further Technology Optimization

Case #4: TAVR for Pure Native Aortic Regurgitation - A Horrifying Ride

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

TAVR Patient Journey III: Behind the Scenes

TAVR Patient Journey II: Imaging Assessment

TAVR Patient Journey I: Initial Evaluation

Off Script: Welcome to TCT 2017 in the Mile High City

Case Presentation 6: BTK Intervention

Editorial Comment

Case Presentation 5: TAVR

Tricuspid Valve Interventions: Patient Selection, Devices, and Predictions

Troubleshooting During Left Atrial Appendage Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content